TIDMN4P

RNS Number : 6711N

N4 Pharma PLC

21 May 2020

21 May 2020

N4 Pharma plc

("N4 Pharma" or the "Company")

Holding in Company

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec(R), a novel delivery system for cancer treatments and vaccines, has been notified that Mr David Farrier's beneficial interest in the Company's share capital remains at 12,175,510 ordinary shares in the Company, representing 8.00 per cent. of the Company's issued share capital. Mr Farrier's holding was diluted through a notifiable threshold as a result of the issue of new ordinary shares in the Company pursuant to the placing announced on 13 May 2020.

Enquiries:

 
 N4 Pharma Plc 
  Nigel Theobald, CEO              Via Scott PR 
 Allenby Capital Limited         Tel: +44(0)203 328 5656 
  James Reeve/Asha Chotai 
 Turner Pope Investments (TPI)   Tel: +44(0)20 3657 0050 
  Ltd 
  Andrew Thacker 
 Scott PR                         Tel: +44(0)1477 539 539 
  Georgia Smith 
 

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec(R).

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec(R) as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLFLFFEESILFII

(END) Dow Jones Newswires

May 21, 2020 11:26 ET (15:26 GMT)

N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas N4 Pharma.
N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas N4 Pharma.